COVID-19 infection during pregnancy has raised concerns since the start of the pandemic. Earlier research showed that the virus could increase the risk of complications such as stillbirth, premature birth, and preeclampsia. Preeclampsia is a dangerous blood pressure disorder that threatens both the pregnant person and the developing fetus.
A recent international study suggests that COVID-19 vaccination may help reduce this risk. Researchers found that coronavirus infection increased the likelihood of preeclampsia by about 45 percent among pregnant participants compared with those who were not infected. The increase was even greater among people who were unvaccinated when they became infected. In that group, the risk rose by roughly 78 percent.
Vaccination appeared to offer meaningful protection. Participants who received the primary COVID-19 vaccination and stayed up to date with booster doses had a 33 percent lower risk of developing preeclampsia. The protective effect was even stronger among those with existing health conditions. Pregnant participants with illnesses such as diabetes or heart disease who received a booster saw their risk fall by about 58 percent.










